Emmaus Life Sciences Inc (EMMA)
0.10
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Emmaus Life Sciences Cash from Investing (TTM): -1.488M for Sept. 30, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
September 30, 2023 | -1.488M |
June 30, 2023 | -1.989M |
March 31, 2023 | -4.705M |
December 31, 2022 | -2.387M |
September 30, 2022 | -2.45M |
June 30, 2022 | -2.836M |
March 31, 2022 | -3.381M |
December 31, 2021 | -6.377M |
September 30, 2021 | -33.10M |
June 30, 2021 | -0.052M |
March 31, 2021 | 3.704M |
December 31, 2020 | 5.47M |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | -0.0208M |
March 31, 2019 | -0.0091M |
December 31, 2018 | -0.0312M |
September 30, 2018 | -0.3618M |
June 30, 2018 | -0.6113M |
March 31, 2018 | -0.7529M |
December 31, 2017 | -0.8105M |
September 30, 2017 | -0.4795M |
Date | Value |
---|---|
June 30, 2017 | -0.2438M |
March 31, 2017 | -0.1607M |
December 31, 2016 | -0.086M |
September 30, 2016 | -0.0823M |
June 30, 2016 | -0.0685M |
March 31, 2016 | -0.0085M |
December 31, 2015 | 0.0015M |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | 0.0014M |
June 30, 2013 | 0.0014M |
March 31, 2013 | 0.0014M |
December 31, 2012 | -0.001M |
September 30, 2012 | -0.0255M |
June 30, 2012 | -0.0274M |
March 31, 2012 | -0.027M |
December 31, 2011 | -0.0288M |
September 30, 2011 | -0.0216M |
June 30, 2011 | -0.0257M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-33.10M
Minimum
Sep 2021
5.47M
Maximum
Dec 2020
-3.816M
Average
-2.387M
Median
Dec 2022
Cash from Investing (TTM) Benchmarks
AIM ImmunoTech Inc | -0.832M |
Perspective Therapeutics Inc | 24.37M |
Protalix BioTherapeutics Inc | -16.71M |
Electromed Inc | -1.219M |
Armata Pharmaceuticals Inc | -8.134M |